Coronavirus LIVE: No Delay In Purchase Agreements With Domestic Vaccine Manufacturers, Says Govt
Coronavirus LIVE Friday, July 23: Kerala, for the past several days, has been leading the rest of the country in daily cases and few other key parameters
An expert group of the Indian govt is still in talks with Pfizer over COVID vaccine supply: Health Minister Mansukh Mandaviya in Lok Sabha.
There has been no delay in entering into purchase agreements with the domestic vaccine manufacturers. Advance payments have also been made to manufacturers for the supply orders placed with them: Dr Bharati Pravin Pawar, MoS (Health) in Lok Sabha.
A total of Rs 9725.15 crore has been spent so far on the COVID19 vaccination programme including procurement of vaccines & operational cost for vaccination: Dr Bharati Pravin Pawar, MoS (Health) in Lok Sabha.
A total of 135 crore doses of COVID-19 vaccine are expected to be available between August 2021 to December 2021: Dr. Bharati Pravin Pawar, MoS (Health) in Lok Sabha.
Delhi: Sub-divisional Magistrate (Patel Nagar) has issued an order for closure/shutting down of Tilak Nagar markets with effect from July 23 to July 27, for flouting COVID-19 norms.
In view of the COVID-19 pandemic and a possible third wave, only a symbolic 'snan' will be held in Haridwar on 24th July on the occasion of Guru Purnima. Only 'Shri Ganga Sabha' and 'Teerth Purohit' to participate in the snan: Haridwar District Administration
Devotees will be allowed in Haridwar if they produce a negative RT-PCR report not older than 72 hours, but they won't be allowed in the 'snan': Haridwar District Administration
Washington: The benefits of the Johnson & Johnson Covid-19 vaccine far outweigh its potential risks amid an ongoing review of reports of a rare neurological disorder, according to an advisory panel to the US Centers for Disease Control and Prevention (CDC) on Thursday.
There have been 8.1 cases of Guillain-Barre syndrome per 1 million doses, which is higher than expected in the general population and close to eight times the rate seen in Pfizer's and Moderna's shots, according to data presented at a meeting of CDC's Advisory Committee on Immunization Practices on Thursday.
Guillain-Barre is a neurological disorder in which the body's immune system damages nerve cells, causing muscle weakness and sometimes paralysis, according to the US Food and Drug Administration (FDA).
The data came after the US Food and Drug Administration (FDA) announced a new warning on July 12 for the Johnson & Johnson shot after preliminary reports of Guillain-Barre syndrome in some recipients, the Xinhua news agency reported.
About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the US, according to the FDA.
Of these reported cases, 95 were serious and required hospitalisation, and one was dead. (IANS)
Background
Coronavirus LIVE Friday, July 23: Maharashtra reported 7,302 new COVID-19 cases and 120 fatalities on Thursday, taking the infection tally of the state to 62,45,057 and death toll to 1,31,038, a health department official said.
As many as 7,756 patients were discharged from hospitals, pushing the number of recovered cases to 60,16,506. There are 5,51,872 people in home quarantine while 3,743 are in institutional quarantine. The state has 94,168 active COVID-19 patients.
Maharashtra's COVID-19 recovery rate is 96.34 per cent, while the fatality rate is 2.09 per cent. Nandurbar, Dhule and Wardha districts and Parbhani city did not record any new infections on Thursday. State capital Mumbai recorded 389 new COVID-19 cases, taking its infection tally to 7,32,971, while its death toll increased to 15,810 with addition of 10 fresh fatalities.
Meanwhile, Delhi had less than a day's stock of coronavirus vaccine left on Thursday morning, prompting the government to issue an order stating that Covishield will only be used for administering second doses till July 31, according to a bulletin.
A total of 48,256 vaccine doses were administered here on Thursday, taking the total number of doses given so far in the national capital to 95,66,720, of which, 23,14,539 are second doses, according to the data available on Co-WIN portal.
The city had 65,460 doses of Covishield left on Thursday morning, it said.
A total of 63,406 vaccine doses were administered in Delhi on Wednesday. Of these, 33,443 were second doses, the bulletin said.
Delhi had received 70,000 doses of Covaxin on Wednesday, taking the total number of available doses to 2,45,590.
Kerala continues to reel under COVID cases in Kerala as 12,818 new cases were detected from 1,03,543 samples tested in the past 24 hours, with the test positivity rate vaulting over 12 per cent, a state government statement said.
Chief Minister Pinarayi Vijayan, in the statement, said 13,454 turned negative, taking the total cured in the state to 30,72,895, while the total active cases stood at 1,28,881
Another 122 COVID deaths were reported, taking the toll to 15,739.
Across the state, 4,09,323 people were under observation at various places, including 25,497 in hospitals.
Kerala, for the past several days, has been leading the rest of the country in daily cases and few other key parameters and according to sources, the state government is planning to conduct a massive testing of over three lakh people on Friday.
- - - - - - - - - Advertisement - - - - - - - - -